4D Molecular Therapeutics, Inc. Common Stock (FDMT)

Health Care·equity

$13.33

+4.96% today

Extended hours $13.25

Prices delayed about 15 minutes · cached page, can be an hour old or more

Market Census Score

55/ 100

Score level

Above average

6 of 6 checks had data

Smart-money score is below the middle; score for how it compares with the broader market is above the middle; and price trend score is on the high side.

FDMT scores higher than 77% of the 1,101 tickers we compare it with (Health Care).

As of 9 October 2026, 4D Molecular Therapeutics, Inc. Common Stock (FDMT) scores 55 out of 100 on the Market Census six-factor composite, which puts it at the Above average score level. The score is made from six named factors: price trend, strength vs the market, company finances, insider trades, market mood and recent momentum. It records what they read on 9 October 2026, and it is not investment advice.

Updated 9 October 2026 · scores usually change about once a day

Key statistics

Market fields as reported. An em-dash means we hold no value for this ticker — most of the universe has no daily price or volume read.

Relative volume: 0.88× 30-day average
52-week range: 6.96 – 16.93
Market cap: $840.82M
Earnings date: 9 Nov 2026

Volume: 868,022
Avg. volume (30d): 990,516

Open: 12.70
Previous close: 12.70
Day's range (regular session): 12.55 – 13.85

The last trade can be an extended-hours trade, so it can sit outside the regular-session range.

Shown without a peer ranking — we hold no percentile for these yet, so there is nothing here to locate them against.

Beta: 2.90
P/E (TTM): —
EPS (TTM): -2.76

Score breakdown · six named factors

Price trend

Strength vs the market

Company finances

Insider trades

Market mood

Recent momentum

Each bar is one part of the score, from 0 to 100. Read what the score means.

Premium data held for FDMT

16 SEC Form 4 insider transactions in the last 90 daysPremium

Counts of rows Market Census holds for FDMT. A dash in the factor table above means that factor has no data for this ticker — it is not a locked value. Compare plans

What the score says about FDMT right now

4D Molecular Therapeutics, Inc. Common Stock (FDMT) currently scores 55/100 on the Market Census six-factor composite, at the Above average score level. FDMT is +4.96% on the day and -2.23% over five sessions as of the most recent tick. Above average sits a bit above the middle. The data for FDMT leans good, with some weak spots. FDMT's strongest factor is price trend at 80/100 — a strong read on which way the price has been going. The weakest factor is insider trades at 16/100 — a well below average read on insider buying and selling. Insider filings for FDMT lean toward selling; on a thinly filed name a few filings can set this reading.

Generated from the six-factor breakdown above. Changes when the underlying scores do, usually about once a day. More on what the score means.

See FDMT in the scanner

This page is free to read with no account at all. Signing up takes an email and a password: a free account runs the scanner on the top 10 scored rows of any scan, keeps one saved screen, a 5-ticker watchlist, and opens 12 ticker detail pages a day. The card is what starts a 30-day Premium trial — $0 that day, then $19.99/month from day 30, cancel online any time before then — and that is what turns on every matching row instead of the first 10, alerts, the 200-ticker watchlist and recent insider buys (SEC Form 4).

Create your account →Share on X Embed this score